Should We Stop Endovascular Treatment of M2 Occlusions?: A Critical Look at Recent Evidence

医学 随机对照试验 血管内治疗 观察研究 闭塞 冲程(发动机) 临床试验 急性中风 重症监护医学 放射科 外科 动脉瘤 内科学 机械工程 工程类 组织纤溶酶原激活剂
作者
Amol Mehta,Daryl Goldman,Eytan Raz,Shashvat M. Desai,Eva Mistry,Thanh N. Nguyen,Sunil A. Sheth,Ashutosh P. Jadhav,Joseph P. Broderick,Pooja Khatri,Johanna T Fifi,Jeffrey L. Saver,J Mocco
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:56 (9): 2819-2829 被引量:9
标识
DOI:10.1161/strokeaha.125.051578
摘要

Medium vessel occlusions represent a substantial proportion of patients with acute ischemic stroke. Recently presented randomized controlled trials, ESCAPE-MeVO (Endovascular Treatment to Improve Outcomes for Medium Vessel Occlusions), DISTAL (Endovascular Therapy Plus Best Medical Treatment [BMT] Versus BMT Alone for Medium Distal Vessel Occlusion Stroke), and DISCOUNT (Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion), did not demonstrate a clinical benefit of endovascular thrombectomy in distal and medium vessel occlusions, potentially generating uncertainty about optimal treatment strategies for medium vessel occlusions. Specifically, these results may lead clinicians to hesitate in performing endovascular thrombectomy for M2 occlusions, despite prior evidence indicating benefit in this subgroup. In this review, we critically examine current literature, focusing on anatomic and functional definitions of M2 segments, and highlight the significant heterogeneity in their classification. We place a particular emphasis on proximal as well as dominant M2 branches and the existing evidence, including observational studies, meta-analyses, and prior randomized trials. Additionally, we discuss methodological limitations and patient-selection biases of recent neutral trials, which may warrant caution in the broad application of their findings. Lastly, we propose recommendations for future research, emphasizing the need for refined patient-selection criteria to better identify subgroups most likely to benefit from endovascular thrombectomy, improved classification systems for M2 occlusions, and the exploration of adjunctive and alternative therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
箭剑尖发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
徐风拂海棠完成签到 ,获得积分10
2秒前
2秒前
2秒前
3秒前
4秒前
4秒前
5秒前
5秒前
挚友发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
5秒前
6秒前
魔幻的觅云完成签到,获得积分20
6秒前
炙热夏寒完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
8秒前
8秒前
8秒前
8秒前
8秒前
9秒前
chengcheng完成签到,获得积分10
9秒前
9秒前
aaa发布了新的文献求助10
9秒前
郑博发布了新的文献求助30
10秒前
11秒前
11秒前
11秒前
11秒前
11秒前
lll发布了新的文献求助10
12秒前
张安安完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184240
求助须知:如何正确求助?哪些是违规求助? 9573297
关于积分的说明 21830585
捐赠科研通 7781300
什么是DOI,文献DOI怎么找? 3434285
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480814